Addus HomeCare (NASDAQ:ADUS) Upgraded by Citizens Jmp to Strong-Buy Rating

Addus HomeCare (NASDAQ:ADUS) was upgraded by equities researchers at Citizens Jmp to a “strong-buy” rating in a report issued on Monday,Zacks.com reports.

A number of other research analysts have also recently weighed in on ADUS. KeyCorp began coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price on the stock. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Oppenheimer lifted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Stephens increased their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Finally, JMP Securities initiated coverage on Addus HomeCare in a report on Monday. They set an “outperform” rating and a $150.00 target price for the company. One analyst has rated the stock with a sell rating, nine have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $133.67.

Addus HomeCare Trading Up 0.2 %

Shares of NASDAQ ADUS opened at $130.73 on Monday. The company has a fifty day moving average price of $125.76 and a 200 day moving average price of $124.69. Addus HomeCare has a 1-year low of $85.94 and a 1-year high of $136.12. The firm has a market cap of $2.37 billion, a PE ratio of 29.92, a PEG ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same period last year, the firm posted $1.03 earnings per share. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. Equities research analysts forecast that Addus HomeCare will post 4.59 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Quarry LP bought a new position in shares of Addus HomeCare in the third quarter worth about $28,000. UMB Bank n.a. increased its stake in shares of Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after purchasing an additional 88 shares in the last quarter. Quest Partners LLC purchased a new stake in shares of Addus HomeCare in the second quarter worth $31,000. Farther Finance Advisors LLC raised its position in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares during the period. Finally, Innealta Capital LLC purchased a new position in shares of Addus HomeCare during the 2nd quarter valued at $44,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.